KB KALA BIO, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the KALA BIO, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €14.5m. The latest transaction was reported on 24 October 2025 (Cession). Among the most active insiders: Iwicki Mark T. The full history is accessible without an account.
€684,821
27 ops.
Sell Volume
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 October 2025
All Executives52 Thresholds0 Prospectus0 Other0
Declarations 52 total
▼ CHIEF BUSINESS OFFICER · Executives · 22 Oct 2025
20,806 shares @ US$0.83 26.1% of flow Common Stock SEC:0001893729-25-000003:0
▼ Director · Executives · 23 Oct 2025
154,894 shares @ US$0.81 32.3% of flow Common Stock SEC:0001415537-25-000004:0
▼ SEE REMARKS · Executives · 22 Oct 2025
46,748 shares @ US$0.83 33.6% of flow Common Stock SEC:0001298079-25-000003:0
▼ CHIEF FINANCIAL OFFICER · Executives · 22 Oct 2025
32,230 shares @ US$0.83 31.4% of flow Common Stock SEC:0001710969-25-000003:0
▼ Director · Executives · 22 Oct 2025
47,768 shares @ US$0.83 37.2% of flow Common Stock SEC:0001605767-25-000004:0
21,376 shares @ US$1.5959 1.5% of flow Common Stock SEC:0001193125-25-228536:0
▼ CHIEF BUSINESS OFFICER · Executives · 24 Jun 2025
4,511 shares @ US$4.01 36.9% of flow Common Stock SEC:0001415889-25-018321:0
▼ CHIEF FINANCIAL OFFICER · Executives · 24 Jun 2025
3,631 shares @ US$4.01 24.9% of flow Common Stock SEC:0001415889-25-018320:0
▼ SEE REMARKS · Executives · 24 Jun 2025
4,058 shares @ US$4.01 24.3% of flow Common Stock SEC:0001415889-25-018319:0
▼ SEE REMARKS · Executives · 24 Jun 2025
5,251 shares @ US$4.01 27.5% of flow Common Stock SEC:0001415889-25-018318:0
▼ Director · Executives · 24 Jun 2025
13,227 shares @ US$4.01 20.2% of flow Common Stock SEC:0001415889-25-018317:0
◆ Director · Executives · 15 Jun 2025
2,450 shares 0Common Stock SEC:0001415889-25-017616:0
◆ Director · Executives · 15 Jun 2025
2,450 shares 0Common Stock SEC:0001415889-25-017615:0
◆ Director · Executives · 15 Jun 2025
2,450 shares 0Common Stock SEC:0001415889-25-017614:0
◆ Director · Executives · 15 Jun 2025
2,450 shares 0Common Stock SEC:0001415889-25-017613:0
◆ Director · Executives · 15 Jun 2025
2,450 shares 0Common Stock SEC:0001415889-25-017612:0
◆ Director · Executives · 15 Jun 2025
3,050 shares 0Common Stock SEC:0001415889-25-017611:0
▼ Director · Executives · 3 Jun 2025
10,866 shares @ US$3.74 19.8% of flow Common Stock SEC:0001104659-25-056986:0
▼ CHIEF FINANCIAL OFFICER · Executives · 3 Jun 2025
2,850 shares @ US$3.74 24.7% of flow Common Stock SEC:0001415889-25-015680:0
▼ CHIEF BUSINESS OFFICER · Executives · 3 Jun 2025
730 shares @ US$3.74 9.0% of flow Common Stock SEC:0001415889-25-015681:0
▼ SEE REMARKS · Executives · 3 Jun 2025
3,390 shares @ US$3.74 25.5% of flow Common Stock SEC:0001415889-25-015679:0
▼ SEE REMARKS · Executives · 3 Jun 2025
3,687 shares @ US$3.74 25.4% of flow Common Stock SEC:0001415889-25-015678:0
▼ Director · Executives · 3 Jun 2025
10,866 shares @ US$3.74 24.7% of flow Common Stock SEC:0001415889-25-015677:0
◆ SEE REMARKS · Executives · 6 Jan 2025
10,100 shares 0Common Stock SEC:0001415889-25-001061:0
◆ SEE REMARKS · Executives · 6 Jan 2025
10,100 shares 0Common Stock SEC:0001415889-25-001062:0
25 of 52 declarations
Load more (27 remaining) 关于 KALA BIO, Inc. KALA BIO, Inc. 是一家生物制药公司，专注于开发创新的眼科疾病治疗方法。该公司在纳斯达克上市，股票代码为 KALA。